Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Eagle Bancorp, Inc. Announces First Quarter 2025 Results and Cash Dividend
-
ARMOUR Residential REIT, Inc. Announces Q1 Results and March 31, 2025 Financial Position
-
Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual
-
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
-
Jayud Global Logistics Files 2024 Annual Report on Form 20-F
-
Origin Bancorp, Inc. Reports Earnings For First Quarter 2025
-
Plexus Announces Fiscal Second Quarter Financial Results
-
King Salman Park Foundation Selects Parsons for Project Management Office Services
-
Interparfums, Inc. Reports Record 2025 First Quarter Sales
-
Origin Bancorp, Inc. Announces Declaration of Quarterly Cash Dividend
-
Triller Group Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
-
Alta Equipment Group Announces Date of First Quarter 2025 Financial Results Release, Conference Call and Webcast
-
Greystone Housing Impact Investors LP Schedules First Quarter 2025 Earnings Conference Call for Wednesday, May 7, 2025 at 4:30 p.m. Eastern Time
-
Raymond James Financial Reports Fiscal Second Quarter of 2025 Results
-
Artesian Water Company Announces the Hiring of Deirdre S. Smith, P.E., as Director of Planning
-
John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal Year 2025 Operating Results Conference Call
-
John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal Year 2025 Operating Results Conference Call
-
Silvaco Announces Date of First Quarter 2025 Financial Results Conference Call
-
Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025
-
Getty Images to Release First Quarter 2025 Financial Results on May 12, 2025
-
First Watch Announces Flagship Location in Heart of Downtown Boston
-
Churchill Downs Incorporated Announces Updates on Capital Projects for Churchill Downs Racetrack
-
Brookline Bancorp Announces First Quarter Results
-
Open Lending to Announce First Quarter 2025 Results on May 7, 2025
-
Horizon Bancorp, Inc. Reports First Quarter 2025 Results
-
TFI International Announces 2025 First Quarter Results
-
Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event
-
Covenant Logistics Group Announces First Quarter 2025 Financial and Operating Results
-
Reliance, Inc. Reports First Quarter 2025 Financial Results
-
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025
-
Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting
-
Jewett-Cameron Expands Operational Efficiency Efforts
-
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Sight Sciences Announces the Release of its Sustainability Report
-
Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients
-
ACV to Report First Quarter 2025 Financial Results on May 7, 2025
-
Highwoods Declares Quarterly Dividends
-
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
-
Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
-
Getty Realty Corp. Announces First Quarter 2025 Results
-
Dragonfly Energy Announces First Quarter 2025 Preliminary Net Sales and Adjusted EBITDA
-
MARA Schedules Conference Call for First Quarter 2025 Financial Results
-
Autolus Therapeutics Highlights Advancing Autoimmune Pipeline at R&D Investor Event
-
Beyond Meat® to Report First Quarter 2025 Financial Results on May 7, 2025
-
RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025
-
Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred Units
-
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th
-
ACV to Report First Quarter 2025 Financial Results on May 7, 2025
-
Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025
-
BBSI Sets First Quarter 2025 Conference Call for Wednesday, May 7, 2025, at 5:00 p.m. ET

